Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial

The aim of this study was to evaluate longitudinal outcomes of recombinant human fibroblast growth factor (rhFGF)-2 plus deproteinized bovine bone mineral (DBBM) therapy in comparison with rhFGF-2 alone for treating periodontal intrabony defects. This study describes 4-year follow-up outcomes of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Seshima, Fumi, Bizenjima, Takahiro, Aoki, Hideto, Imamura, Kentaro, Kita, Daichi, Irokawa, Daisuke, Matsugami, Daisuke, Kitamura, Yurie, Yamashita, Keiko, Sugito, Hiroki, Tomita, Sachiyo, Saito, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688011/
https://www.ncbi.nlm.nih.gov/pubmed/36421696
http://dx.doi.org/10.3390/biom12111682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688011/
https://www.ncbi.nlm.nih.gov/pubmed/36421696
http://dx.doi.org/10.3390/biom12111682

Ejemplares similares